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THINK PIECES 
Dr. Ram’s triage 
Categorization, speculation, and granting access  
to global health technologies in Indian private clinics 
Andrew McDowell 
Abstract  
Triage is a process of categorizing potential health and guiding care. It is based on the idea 
that all bodies are equal while potential vitality is not. I examine the triage processes used by 
Indian physicians as they collaborated with global health researchers to identify patients for a 
free, cutting-edge tuberculosis test. As I argue, triage forms and reforms social difference 
within global health despite its aspirations of standardization and experimentality. 
Problematizing triage as part of global health’s ordinary affect of affordability reveals local 
biologies, class biopolitics, and clinical speculation in the field. I conclude by considering 
new avenues of ethnographic inquiry that are opened by attending to the practiced and 
depoliticized biopolitics that occurs within clinics as everyday, nonreflexive decisions about 
how to organize resources and speculate on vitalities.  
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My notes read: 
Dr. Ram’s clinic, Sunshine Hospital, Hyderabad, 2:45 PM. 
‘I don’t use it [Xpert, a genetic test for tuberculosis] as a screening test. It’s very 
costly. So, I want to be reasonably sure that I’m using the test responsibly before I 
order it. Usually I ask for a TB [tuberculosis] skin test and want it to be positive 
alongside quite a few sentinel symptoms before I order. At the same time, if I have a 
positive skin test and a positive x-ray, then I don’t need the Xpert test. I can save that 
money for another patient. Even if it’s not the patient who pays, still I should be 
responsible with the resources we have and only order the test for those I think it 
might be most useful for’. 
Dr. Ram’s comment, which he made during a moment between two patient consultations on 
a sultry May afternoon in 2016, prompted me to think about triage. As I had observed in this 
busy private clinic, Dr. Ram and colleagues made split-second decisions as they triaged 
patients, ordering and fitting them into populations. In India, such private-sector 
consultations average from two to four minutes (Das et al. 2012; Irving et al. 2017). In these 
fleeting moments, triage is a constant adjustment in light of unfolding technical and social 
uncertainties (Solomon 2017). Physicians attempt to chart a course among many possible 
clinical actions: those determined necessary at all costs, or ideal, or perhaps avoidable, or 
impractical. Triage is, therefore, contingent as it guides a physician’s clinical course of action 
differently for different patients. 
Ethnographies of triage beautifully situate its contemporary form as an effect of global 
structures, such as humanitarianism, austerity, and transnational governance. Analyzing 
Médecins Sans Frontières, Peter Redfield (2013) reveals that humanitarianism’s moral call to 
action depoliticizes triage’s biopolitical questions about who receives care by answering them 
through mundane considerations of operability, logistics, staffing, finances, and 
management. Similarly, Alice Street’s (2014) ethnography of a Papuan hospital shows how 
the hospital’s scarce technologies prioritize the diseases identified in patient care and public 
health by furnishing evidence to guide a course of action. Studying Côte d’Ivoire-based HIV 
treatment programs, Vinh-Kim Nguyen (2010) finds that triage advances certain subjects 
and subjectivities that match institutional priorities toward life-saving treatment before 
others. He considers the political and biological effects of creating and triaging categories of 
subjects for whom care can be delivered to best effect.  
I follow these interventions by attending to triage as a sociotechnical and political process 
shaped inside and outside of clinics. My encounter with Dr. Ram’s triage, however, requires 
that I stretch this literature. I consider how depoliticized decisions about care unfold in a 
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clinical encounter and shape global health’s tools for making sense of the world in the 
process. To interpret these encounters and their effects, I bring considerations of affect, 
speculation, and technology to bear on Dr. Ram’s triage.   
Organized around his ‘responsibility’ to parsimoniously prescribe free tests for sick children, 
Dr. Ram’s clinical actions reveals that triage is a central node in his connection to global 
health. Triage, for both Dr. Ram and global health, manages scarcity by assessing and 
categorizing a patient’s physical state before imagining her potential to maximize clinical or 
collective resources by regaining health.  
Dr. Ram’s connection to global health and his sense of responsibility to it began in 2014, 
two years before I met him. Researchers specializing in global health diagnostics had 
enrolled him, along with other physicians across four Indian cities, in a project to improve 
access to Xpert and evaluate the test’s utility in India. Project researchers encouraged 
collaborating physicians to send as many children to Xpert testing as possible. When he and 
I met two years later, I learned that researchers had been calling and visiting physicians like 
Dr. Ram in their clinics since enrollment; they had also provided seminars and even invited 
physicians to lunch and dinner. As part of these interactions, researchers explained that 
Xpert machines screen all kinds of samples for TB genes to quickly identify TB and its drug 
resistance. They also emphasized that TB in children is ambiguous and the disease 
progresses rapidly toward debility and death. Ambiguous clinical presentation and rapid 
disease progression, they argued, meant that physicians often struggle to diagnose children 
until it is too late. They even cited data, like those published in 2019, showing that Indian 
physicians only identified 59% of children predicted to suffer from TB (Central TB Division, 
2019 46). By liberally prescribing this test, the researchers suggested, pediatricians could 
quickly diagnose TB, alleviate suffering, and perhaps save young lives. Moreover, the test 
was free to patients. 
Though Xpert was free to patients as part of the project, Dr. Ram and his colleagues knew 
that the test was available on the market for 2000 rupees (US$28). Dr. Ram reasoned that the 
researchers must pay for tests at that cost, which was, respectively, ten and twenty times 
higher than the X-ray and TB exposure tests he used to diagnose TB. In an attempt to help 
conserve resources, he decided to continue to rely on these less precise tools to determine 
whom he would enroll in the project. 
The researchers, on the other hand, wanted to prove that Xpert was superior to older 
methods of diagnosing TB in children. For them, more patients and samples tested meant 
increased statistical power, humanitarian action, and the potential for global scale-up. Paying 
for the test, they reasoned, was the cost of these outcomes. Nonetheless, free-of-cost 
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services imbued their medical research project with a philanthropic aura of urgency and 
gifting (McGoey, Reiss, and Wahlberg 2011; Birn 2014; McGoey 2015).  
Anthropologists have described interventions designed to simultaneously test and implement 
global health technology, like this one, as a form of global heath governance called 
‘experimentality’. Critiques of experimentality suggest that research on the efficacy of drugs, 
diagnostics, or interventions is a central way of extending routinized forms of care and 
governmentality to patients and physicians on the biomedical periphery (Sunder Rajan 2006, 
2017; Petryna 2009; Nguyen 2009). In this case, researchers used the experimental form – 
complete with control areas, detailed evidence making, cost efficacy analysis, and tours by 
circulating expert publics – to increase knowledge about the tool’s utility as well as to 
increase access to it (Shapin and Schaffer 1985; Knorr-Cetina 1992; Rheinberger 2001). The 
project gave Indian children access to a cutting-edge diagnostic tool that many of their 
families could not easily afford and the state would not readily provide. In return, the 
researchers studied the test’s ability to identify disease, documented its effect on clinical care , 
and published their findings. Experimentality had two clear results: first, the strong 
connection researchers and clinicians made between experimental form and rationality 
tempered potential concerns about testing technology on poor children. Second, 
experimentality folded the kinds of difference that Dr. Ram used to triage those ‘most 
needing’ a philanthropic and experimental project into global health’s seemingly universal 
categories.  
Observing Dr. Ram and others reserve global health resources for patients who, as he put it 
‘really needed philanthropy’, I realized that processes of triage and graduated care linked 
technological imaginaries, biological futures, and social categories. Dr. Ram and his 
colleagues – using their clinical sense, low-cost screening tests, and intuitive assessments of 
socioeconomic class – reserved the free advanced global health diagnostic for a specific 
group of patients they judged to be poor. Specifically, they reserved free tests for patients 
who had not, when tested with cheaper tools, received a definitive diagnosis.  
Dr. Ram made triage decisions both before and after inconclusive results obtained from 
inexpensive technology. In these decisions, Dr. Ram used class-like categories to identify 
families that might need global health researchers’ free services. He compelled to the market 
those patients for whom other tools were inconclusive and seemed able to afford Xpert (Li, 
2014). All things being equal, it was Dr. Ram’s affective impression of each patient’s ability 
to pay that shaped his decisions about triage.  
Anthropologists worry that knowledge practices central to global health, such as pilot 
projects and systematic trials, standardize and financialize human life. Have these worries led 
us to overlook the new bodily and social experiences that triage creates when global health, 
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physicians, and patients meet? When determining possible clinical actions – like referral to a 
global health project – Dr. Ram combined global health and his own economic, biological, 
cultural, technical, and medical categories. The intersection of local and global categories 
occurs in triaged bodies, where they produce a diversity of illness experiences, disease 
presentations, and ways of doing medicine. What might the persistence of social categories 
in Dr. Ram’s triage processes say about the forms of difference that occur when 
experimentality reigns? Can examining triage move beyond worries about the global 
standardization of bodies and disease experiences to focus anthropological energies on how 
global health revitalizes and naturalizes categories like class, caste, nation, or even race?  
Affective action 
I was reminded of Dr. Ram a few months later when chatting with Dr. Shyam in his own 
Mumbai-based private clinic. Dr. Shyam explained his process for selecting patients to enroll 
in another major global health-sponsored TB intervention using Xpert. He said, ‘I send all of 
my nonaffording patients to the project’s services. The others I send to specialists without 
telling them about the free services’. I was accustomed to the phrase ‘nonaffording’ and had 
observed a tendency among physicians to send patients they identified as such toward global 
health interventions. Yet, even after months of ethnography I could not understand how 
physicians assessed ‘affording’ and ‘nonaffording’.  
When I asked Dr. Shyam how he did so, he told me, ‘Most of them [patients] I have known 
for years’. I said I imagined it was challenging to know intimate and shifting details about a 
particular family’s economic state in Mumbai’s large and diverse slums. He responded, ‘Sure, 
but I know how big their family is, usually, where they work. And, you know, I can see how 
they dress and hold themselves. I can understand it in the questions they ask. Like, if they 
ask a lot about cost, probably they are not affording. If they carry a fancy phone or have nice 
jewelry, probably they are. Don’t forget that knowing people is my job here too’. Indeed, this 
physician’s analysis of a family’s ability to pay was a combination of aesthetic assessment, 
local context, and his own affective sense. He ‘just knew’.  
Dr. Shyam could ‘simply tell’ who might be a global health patient. Global health’s resources, 
he assumed, should be reserved for patients whose symptoms were of interest to global 
health’s cost-over-global-epidemiological-effect calculus (Reubi 2018). But as importantly, 
global health patients were people who could not afford, in economic, social, or temporal 
terms, to access the market. Determining ability to access the market was a central part of 
Drs. Shyam and Ram’s triaging patients to or away from global health programs. If the 
patient would pay for Xpert services on the market, then the test’s effect would be the same. 
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The cost in global health resources, however, was far higher. If the patient could not access 
the market, then the cost to global health resources would be justifiable or ‘responsible’. 
Intuitive determinations of ‘affording’ and ‘nonaffording’ patients alongside the intuited 
impetus to act responsibly with global health money are examples of Kathleen Stewart’s 
‘ordinary affects’. ‘Ideologies happen’, she writes. ‘Power snaps into place. Structures grow 
entrenched. Identities take place. Ways of knowing become habitual at the drop of a hat. But 
it’s ordinary affects that give things the quality of something to inhabit and animate’ (Stewart 
2007, 15).  
Triage is an ordinary affect, an unreflexive decision about who to protect and who to compel 
to the market, that helps Drs. Ram and Shyam ‘inhabit and animate’ global health. Triage 
makes global health and experimentality localizable, knowable, and rational. Neither of the 
men read global reports or sit at tables in Seattle or Geneva. They sense their way through 
the complicated work of ‘global health’ to identify maladies and populations that might be 
managed by the market and those that represent risks best not exposed to market 
competition. NGO staff visit physicians’ clinics with targets, promises of free services to 
certain patients, and information about new global health priorities. By using their sense of 
need to triage patients toward and away from NGO workers’ global health interventions, the 
doctors become part of or animate one of global health’s ordinary affects.  
Global health’s triage is not a purely clinical practice. Affective senses of who may not be 
able to access the market also inflect global discussions of Xpert’s costs. At a global meeting 
of TB experts, in a European capital in 2017, many test developers and intervention 
scientists considered the US$35 cost per test too expensive for a global scale-up. Like the 
terms ‘affording’ and ‘nonaffording’ in Mumbai, intuitions about ‘affordability’ circulated as 
test designers, epidemiologists, and interventionists speculated about the amount 
governments, the market, and global philanthropy institutions were willing to pay per test. 
Conversations that unfolded in expert meetings around questions of price and value have 
rather swiftly turned into practices of triage in Dr. Ram’s clinic.  
Projects, like those that enrolled Drs. Ram and Shyam, allow Indian private-sector physicians 
to inhabit global health and its ordinary affects. Triage, affordability, scarcity, and ‘need’ are 
connective tissues that join situated physicians and mobile researchers. Michelle Murphy 
describes a similar assemblage of experimentality and audit that connects family planning 
interventions in Bangladesh and its projected global effect. She argues that ‘the epistemic 
infrastructures of surveillance that generated such numbers were as much projects of 
statistical rationality as they were of affective rearrangement. … Affect does not just animate 
numerical sums; it was purposively propagated by that infrastructures that do the counting’ 
(Murphy 2017, 60). Like Murphy’s historical actors, Drs. Ram and Shyam are enmeshed in 
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an infrastructure that is permeated by affects of affordability. Ordinary affects of 
affordability rearrange relationships that once prioritized care over counting and cost, 
allowing the two doctors to inhabit and practice calculi that privilege the assessment of care’s 
utility through cost and accessibility on the market. They do so by aligning with a familiar 
cognate of prioritization: triage. In triage, physicians unreflexively follow global health’s 
guide when making very political divisions about who can and should receive care.  
Certainly, a physician would not consciously deny the best possible care to a patient who 
may have a life-threatening disease. And yet, they often do. Drs. Ram and Shyam affectively 
animate and inhabit global health’s discourses of scarcity. They make them real in triage. 
Speculative imaginaries 
Medical anthropology characterizes global health as a set of epistemes and practices designed 
to understand human life in terms of comparable biology and risk at a planetary level (Biehl 
and Petryna 2013; Crane, 2013; Adams 2016; Packard 2016). The discipline’s examination of 
global health’s use of and influence on biomedicine leads me to consider the effects of triage 
on the forms of human life that global health fosters. Though global health’s assumptions of 
globally uniform humanity repudiate biologized racism and ethnic difference, its practice of 
identifying populations particularly at risk for or afflicted by individuated diseases builds 
collectivities of difference. In his patient triage practices, Dr. Ram created diversity by 
identifying unique populations that corresponded to the different manifestations of TB that 
could be identified by inexpensive X-ray or skin tests and expensive Xpert technologies. 
Furthermore, global health hierarchically organizes disease categories by their urgency for 
human economic and physical vitality at a global scale (World Bank 1993). This 
categorization and prioritization is triage, and though triage in Europe and North America is 
largely confined to emergency care, austerity policies propagate forms of triage also in 
nonemergency settings in medical systems there, too (Kentikelenis 2015; Chabrol, David, 
and Krikorian 2017).  
Fundamentally, triage allows a depoliticizing embrace of human equity. Medical 
determinations of who can wait and who is too sick to effectively use treatment have origins 
in late eighteenth-century European battlefields, French egalitarianism, and Benthamian 
utilitarianism (Mitchell 2008; Redfield 2013). Triage was originally used to categorize injured 
soldiers based on an intervention’s likelihood of success as well as the soldier’s condition, 
ability to wait, and possible return to battle. Prioritizing soldiers’ care by health instead of 
social status, French surgeons enacted republican equality. In its idealized form at least, 
triage used medical assessments of care’s urgency and potential effect; these superseded 
social categories, hierarchy, and politics.  
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Triage left the battlefield when operations research and systematic prioritization entered 
discourses of health and development after World War II (Mahalanobis 1955; Andersen 
1964). It shifted from managing individual patients in emergency to guiding the care of 
populations toward future increases in vitality. Off the battlefield and in the bureaucracy, 
triage inflects how physicians like Dr. Ram see and react to the people in their care. 
Nonetheless, categorizing who needs care or health resources in contemporary India is a 
complex process. It includes assessing the level of need, cost of care, and clinical utility in 
the context of a patient’s imagined future of vitality or death.  
Today, as on the battlefield, triage is both pragmatic and future oriented. It uses possible, 
imagined futures to determine pragmatic action in the present. As such, triage is speculative 
(Peterson 2014). As Dr. Ram speculated about his patient’s bodily future in an attempt to 
determine which resources to mobilize, he enlivened the categories that are part of the 
enterprise of triage. Though categorizing a patient’s financial and physical possibility is a 
small and unreflexive part of a clinical encounter, it guided his clinical decisions about which 
patients to send to his global health collaborators. More precisely, Dr. Ram’s situated 
categorization of patient needs and futures affected global health’s evidence. By sending only 
a small portion of his patients to the project, he localized the sample that global researchers 
will use to make claims about its technical and global utility. Including only particularly poor 
patients or those with nonspecific disease presentations in a global health experiment builds 
and rebuilds populations of difference in global health’s aspirationally postracial, postclass 
equality. Experimentality even inscribes these differences in its technical possibilities.  
Triage is a speculative form of biopower. It operates by deciding whose lives should be 
fostered and whose should be allowed to die through state or social neglect (Foucault 1978), 
but it makes such decisions by speculating on the potential cost and population-level effects 
of a fostered or neglected life. Though the effect of providing a test can never be known 
before the result and patient’s response to treatment, physicians aim to predict the test’s 
result and its broader impact as part of their triage. At the same time, Dr. Ram’s work shows 
that even though biopolitical processes are political acts in which justice, resource 
distribution, and rights are at play, they are often experienced and lived as if they were 
apolitical, objective, or simply practical (Ferguson 1994; Harper and Parker 2014). Dr. Ram’s 
biopolitical actions played out in his subjective, intuitive assessments of need, triage, and 
operability.  
The politics of life are thus reduced to matters of triage rather than requiring a decision 
about rights, justice, and life itself. Depoliticizing health care decisions via triage does not 
just happen in moments when metrics determine intervention priorities through costs and 
effects. It also occurs when a decision assessing the need for care in a global health 
intervention is made on moral grounds or its grounds are left unconsidered. 
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Technical triage 
As part of an experimental research program, Dr. Ram’s assumptions about nonaffording 
patients and his choice to send them to the project were taken up into global heath’s 
published conversations about the test’s capabilities, target populations, and key 
beneficiaries. Dr. Ram’ perspectives – that global health resources should be spent on the 
poor, that drug resistance in children is limited, that poverty has a clinical presentation, and 
that limited global health resources can be apportioned in the clinic – inflected his triage of 
patients to and from the project designed to assess the potential of Xpert technology.  
Triage and technology came together in Dr. Ram’s clinic as he rationed global health’s 
philanthropic capital. Global health discourses of scarcity, risk, and prioritization have hailed 
Dr. Ram. Like many of the hundreds of Indian physicians I observed and interviewed about 
TB diagnosis and drug resistance, he assessed the cost and effectiveness of diagnostic 
technologies as part of his regular clinical routine. Before joining the Xpert project, Dr. Ram 
used his clinical sense and tools like X-ray and the tuberculin skin test on all patients. In the 
new context of the project, Dr. Ram reorganized the impressionistic, clinical, and economic 
blueprint he used to speculate about a test’s likelihood of clinically actionable information, 
his patients’ need for that test, and their ability to purchase it. He directed those patients for 
whom Xpert information was essential but too costly to the program. He referred those who 
needed Xpert testing and who could access it in the market to the market. For those he 
could diagnose without Xpert testing, he began treatment, unless they could afford Xpert 
and insisted on its precision.  
Dr. Ram’s striated use of technology for different patients created three populations where 
before only one had existed. The first group, by far his largest, were patients he diagnosed 
with the older logarithm of skin test and X-ray. Without access to the Xpert test, they had no 
evidence of bacteria in their bodies, no definitive proof of TB, and no information about the 
probable utility of the standard TB treatment. As X-ray and skin tests cannot confirm 
bacteria or know its susceptibility to drugs, these patients will not enter the global group of 
TB sufferers, regardless of the presence or absence of disease. Even after many months of 
pharmaceuticals, determining the effect of treatment is difficult because the absence of 
never-identified bacteria does not evidence a change of state from infected to cured. 
Identifying and treating TB on the basis of X-ray and skin test results alone leads to the 
missed diagnoses and advanced disease in children that the use of the more sensitive Xpert 
technology promises to prevent.  
Dr. Ram’s triage, however, separated those patients he sent for Xpert testing into two 
different populations. Patients in both populations learned of the presence or absence of 
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bacteria in their bodies. They also knew if their treatment was likely to work, because Xpert 
provides information about the bacteria’s ability to resist certain pharmaceuticals. They are 
not a single population, however, because those patients sent to the program entered into a 
community of people on whose data global health knowledge is made, while those who 
accessed the market did not. Patients enrolled in the project, their disease, and their data 
joined an experimentality that creates knowledge to be used all over the world. They became 
at once part of a population that is the global standard and the exception. Those who 
accessed the market entered a population that avoided becoming points to be averaged into 
the globally standard data, but not totally, because global health’s experimentality and affects 
of affordability shaped this practice throughout. Their status as a population for global 
health was not fully formed. 
Dr. Ram’s triaged access to testing produced several new, local TBs in the same moment as 
it inflected the global standard away from easily diagnosed cases and TB among the rich. It 
created a local biology by identifying and bringing to global biopolitics those children whose 
bodies have also been marked by poverty (Lock 1993). In the bodies of children who receive 
treatment without testing to establish drug resistance, this approach to triage grows local 
microbiologies by haphazardly exposing bacteria to antibiotics (Koch 2011). In other words, 
by triaging affording and nonaffording patients in and out of standardized care, Dr. Ram not 
only altered the standard and what global health may know about TB; he changed the 
bacteria themselves. By haphazardly exposing bacteria in some patients to ineffective 
pharmaceuticals while systematically eradicating bacteria in others, he fueled and dampered 
bacterial evolution. At the same time his triage, through its connection to experimentality, 
inflected assumptions about how Xpert works, where services should be located, who might 
be ideal patients, and how to use the test to best effect the world over. 
In this kind of frugal experimental global health, triage categorizes disease states and 
organizes technical action while changing both of them. By providing differentiated care, Dr. 
Ram naturalized analytical categories like ‘affording’ and ‘nonaffording’, as global health 
actors identify their population of concern and their most effective tools. In the process, 
certain premises become self-fulfilling prophesies: that drug resistance is rare, that forms of 
pulmonary TB easily detected by cheap tests like X-ray and skin test are rare in children, that 
hard-to-diagnose forms of TB requiring Xpert testing and drug resistance are common in the 
poorest patients, and that Xpert may be more expensive than useful.  
Feeling triage(d) 
Attending to Dr. Ram’s experienced (if not imposed) responsibility to manage cost, his 
mobilization of the class-like categories ‘affording’ and ‘nonaffording’, and his assessments 
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of ‘affordable’ and ‘expensive’ helps make connections among global health’s many scales. 
These connections also highlight ways that speculation, experimentality, and affect create 
forms of triage that make withholding higher-quality diagnostics both normal and moral. 
This is a conclusion in and of itself, but its implications for the anthropological study of 
global health are key. Attending to triage as an affective, speculative, and experimental 
practice suggests that a second body of ethnographic work might emerge alongside the 
nuanced studies examining the reflexive knowledge processes that global health institutions 
use to know their objects, set goals, and measure successes and failures. This research must 
consider nonreflexive, intuitive, or affective ways of knowing in global health. It must 
analyze intuitive processes’ parallel effects on experimentality, institutions, and bodies.   
Considering Drs. Ram and Shyam’s triage provides one example of the ways global health 
might be understood and theorized, by considering the categories it takes for granted and 
disseminates affectively. By attending to affective aspects of categorization, new forms of 
connectivity, speculation, and the technological sensing of potential health come to the fore. 
From a critical consideration of categories and their affective aspects, important nodes of 
connections among global health institutions, experimentality, and clinical care practices can 
emerge for analysis.  
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